Articles with "lch" as a keyword



Photo by nci from unsplash

CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH‐associated neurodegeneration and mass lesions

Sign Up to like & get
recommendations!
Published in 2018 at "Cancer"

DOI: 10.1002/cncr.31348

Abstract: Central nervous system Langerhans cell histiocytosis (CNS‐LCH) brain involvement may include mass lesions and/or a neurodegenerative disease (LCH‐ND) of unknown etiology. The goal of this study was to define the mechanisms of pathogenesis that drive… read more here.

Keywords: langerhans cell; cell histiocytosis; mass lesions; lch ... See more keywords

High levels of plasma interleukin-17A are associated with severe neurological sequelae in Langerhans cell histiocytosis.

Sign Up to like & get
recommendations!
Published in 2019 at "Cytokine"

DOI: 10.1016/j.cyto.2019.154877

Abstract: OBJECTIVE Langerhans cell histiocytosis (LCH) is a granulomatous inflammatory myeloid neoplasia associated with a cytokine storm in both serum and lesions. Increased levels of plasma interleukin-17A (IL-17A) in LCH patients have been reported, but this… read more here.

Keywords: langerhans cell; levels plasma; 17a lch; cell histiocytosis ... See more keywords

Isolated eyelid neonatal Langerhans cell histiocytosis

Sign Up to like & get
recommendations!
Published in 2024 at "Orbit"

DOI: 10.1080/01676830.2023.2300802

Abstract: ABSTRACT Langerhans cell histiocytosis (LCH) is a condition characterized by clonal proliferation of the phagocytic cells derived from the bone marrow. In this article, we present an exceedingly rare case of congenital/neonatal LCH in a… read more here.

Keywords: neonatal lch; isolated eyelid; lch; cell histiocytosis ... See more keywords

Anti TNF-α therapy in patients with relapsed and refractory Langerhans cell histiocytosis: a phase II study

Sign Up to like & get
recommendations!
Published in 2018 at "Pediatric Hematology and Oncology"

DOI: 10.1080/08880018.2018.1539149

Abstract: Abstract Tumor necrosis factor alpha (TNF-α) is produced in Langerhans cell histiocytosis (LCH) lesions and is elevated in plasma of patients with active LCH. It has been postulated that TNF-α may play a role in… read more here.

Keywords: langerhans cell; study; cell histiocytosis; anti tnf ... See more keywords

Efficacy and safety of vemurafenib in Langerhans cell histiocytosis (LCH): A systematic review and meta-analysis

Sign Up to like & get
recommendations!
Published in 2022 at "Pediatric Hematology and Oncology"

DOI: 10.1080/08880018.2022.2072986

Abstract: Abstract Almost half of the patients with Langerhans cell histiocytosis (LCH) are refractory to primary induction chemotherapy or undergo reactivation. The ideal treatment modality for refractory/relapsed LCH is yet not evidenced. This review aimed to… read more here.

Keywords: vemurafenib; langerhans cell; histiocytosis lch; lch ... See more keywords

Advances in our understanding of genetic markers and targeted therapies for pediatric LCH

Sign Up to like & get
recommendations!
Published in 2024 at "Expert Review of Hematology"

DOI: 10.1080/17474086.2024.2353772

Abstract: ABSTRACT Introduction Langerhans cell histiocytosis (LCH) is a rare myeloid neoplasm, encompassing a diverse clinical spectrum ranging from localized bone or skin lesions to a multisystemic life-threatening condition. Over the past decade, there has been… read more here.

Keywords: targeted therapies; genetic markers; lch; pediatric lch ... See more keywords

Adult Langerhans’ cell histiocytosis with multisystem involvement

Sign Up to like & get
recommendations!
Published in 2018 at "Medicine"

DOI: 10.1097/md.0000000000013366

Abstract: Rationale: Langerhans’ cell histiocytosis (LCH), also called histiocytosis X, is an uncommon disorder manifesting in a variety of ways. Although LCH can involve various organs including bone, skin, and lymph nodes, multisystem involvement of LCH… read more here.

Keywords: langerhans cell; histiocytosis; cell histiocytosis; bone ... See more keywords

Delayed diagnosis of pituitary LCH with BRAFV600E mutation: A case report and literature review

Sign Up to like & get
recommendations!
Published in 2025 at "Medicine"

DOI: 10.1097/md.0000000000045274

Abstract: Rationale: This case report highlights the diagnostic challenges and clinical complexities of adult-onset pituitary Langerhans Cell Histiocytosis (LCH), a rare entity with a prolonged and indolent progression. This underscores the critical need for heightened clinical… read more here.

Keywords: lch; brafv600e mutation; case report;

A challenging diagnosis of Langerhans’ cell histiocytosis with hypothalamic-pituitary and mandibular involvement: case report and literature review

Sign Up to like & get
recommendations!
Published in 2024 at "Annals of Medicine and Surgery"

DOI: 10.1097/ms9.0000000000002160

Abstract: Background: Langerhans cell histiocytosis (LCH) is a rare bone marrow derived neoplasm that mainly affects children. It is a multiorgan disorder and hypothalamic-pituitary involvement is uncommon. LCH reveals a wide spectrum of indications; thus, the… read more here.

Keywords: diagnosis; hypothalamic pituitary; lch; case ... See more keywords
Photo from wikipedia

High prevalence of peripheral lymphopenia in Langerhans cell histiocytosis

Sign Up to like & get
recommendations!
Published in 2020 at "British Journal of Haematology"

DOI: 10.1111/bjh.16923

Abstract: In the inflammatory myeloid neoplasia called Langerhans cell histiocytosis (LCH), leukocytes accumulate in tissues causing granulomatous lesions. The disease ranges from mild (singlesystem, SS) to severe (multisystem, MS) manifestations with potential involvement of risk organs… read more here.

Keywords: lymphopenia; diagnosis; treatment; prevalence ... See more keywords

Targeting of SIRPα as a potential therapy for Langerhans cell histiocytosis

Sign Up to like & get
recommendations!
Published in 2023 at "Cancer Science"

DOI: 10.1111/cas.15758

Abstract: Langerhans cell histiocytosis (LCH) is a rare neoplastic disorder characterized by inflammatory lesions arising from the anomalous accumulation of pathogenic CD1a+CD207+ dendritic cells (DCs). SIRPα is a transmembrane protein highly expressed in myeloid cells such… read more here.

Keywords: cd11c; langerhans cell; lch; cell histiocytosis ... See more keywords